Sign in

CIK 0001043961

  • Non-accelerated filer
  • Smaller reporting company

Precipio, Inc.

Sign in to watch
Ticker
PRPO
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
911789357
Phone
+1 203-787-7888
Business address
4 SCIENCE PARK, NEW HAVEN, CT, 06511
Former names
TRANSGENOMIC INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-01-02 Gage Matthew Chief Financial Officer Grant or award · Stock Option (Right to Buy) +5,000 5,000
2025-01-14 Gage Matthew Chief Financial Officer Grant or award · Stock Option (Right to Buy) +4,000 4,000
2024-08-31 Gage Matthew Chief Financial Officer Returned to the company · Stock Option (Right to Buy) −166 0
2024-08-31 Gage Matthew Chief Financial Officer Grant or award · Stock Option (Right to Buy) +166 166
2024-08-31 Gage Matthew Chief Financial Officer Returned to the company · Stock Option (Right to Buy) −133 0
2024-08-31 Gage Matthew Chief Financial Officer Grant or award · Stock Option (Right to Buy) +133 133
2024-08-31 Gage Matthew Chief Financial Officer Returned to the company · Stock Option (Right to Buy) −375 0
2024-08-31 Gage Matthew Chief Financial Officer Grant or award · Stock Option (Right to Buy) +375 375
2024-08-31 Gage Matthew Chief Financial Officer Returned to the company · Stock Option (Right to Buy) −400 0
2024-08-31 Gage Matthew Chief Financial Officer Grant or award · Stock Option (Right to Buy) +400 400
2024-08-31 Gage Matthew Chief Financial Officer Returned to the company · Stock Option (Right to Buy) −500 0
2024-08-31 Gage Matthew Chief Financial Officer Grant or award · Stock Option (Right to Buy) +500 500
2024-08-31 Gage Matthew Chief Financial Officer Returned to the company · Stock Option (Right to Buy) −1,250 0
2024-08-31 Gage Matthew Chief Financial Officer Grant or award · Stock Option (Right to Buy) +1,250 1,250
2024-08-31 Gage Matthew Chief Financial Officer Returned to the company · Stock Option (Right to Buy) −1,000 0
2024-08-31 Gage Matthew Chief Financial Officer Grant or award · Stock Option (Right to Buy) +1,000 1,000
2024-06-21 Gage Matthew CFO Grant or award · Stock Option (Right to Buy) +4,000 4,000
2023-01-06 Gage Matthew See Remark Grant or award · Stock Option (Right to Buy) +75,000 75,000

Page 1 of 1 · 18 trades